Amgen Inc. closed 16.06% short of its 52-week high of $346.85, which the company reached on July 25th.
Citi analyst Geoff Meacham maintained a Hold rating on Amgen (AMGN – Research Report) today and set a price target of $295.00. The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
